Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Oxytocin for Primary Postpartum Hemorrhage
NCT00116350Phase 3Completed
- Sponsor
- Gynuity Health Projects
- Start
- Jul 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Gynuity Health Projects. Primary endpoint: Need for additional treatment after initial PPH study treatment. Started Jul 2005; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT00116350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116350.